(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Giga, Gulf Coast Ultra Deep Royalty Trust, and Niu Technologies.

The three biggest losers today are Nikola, Canopy Growth, and CarMax.

Winners today

1. Giga (GIGA) – 19.17%

Giga-tronics Incorporated, together with its subsidiaries, develops and manufactures electronics equipment for military test and airborne operational applications in the United States and internationally. It operates through two segments, Microsource and the Giga-tronics Division. The company develops microwave components; Band Reject Filters for RADAR/EW (electronic warfare) for solving interference problems in RADAR/EW applications, as well as low noise oscillators used in shipboard and land-based self-protection systems; and RADAR filters for military fighter jet aircraft. It also designs, manufactures, and markets functional test systems for the RADAR/EW equipment of the defense electronics market. The company serves prime defense contractors, the armed services, and research institutes. Giga-tronics Incorporated was incorporated in 1980 and is headquartered in Dublin, California.

NASDAQ ended the session with Giga jumping 19.17% to $0.14 on Thursday, following the last session’s upward trend. NASDAQ jumped 1.68% to $16,442.20, following the last session’s downward trend on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, Giga has a trailing twelve months EPS of $-3.48.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -154.66%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 33.3%, now sitting on 36.6M for the twelve trailing months.

Volume

Today’s last reported volume for Giga is 1000 which is 6.97% below its average volume of 1075.

Moving Average

Giga’s worth is higher than its 50-day moving average of $0.13 and way under its 200-day moving average of $0.19.

Volatility

Giga’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.44%, a negative 3.25%, and a positive 23.69%.

Giga’s highest amplitude of average volatility was 17.10% (last week), 16.40% (last month), and 23.69% (last quarter).

More news about Giga.

2. Gulf Coast Ultra Deep Royalty Trust (GULTU) – 8.72%

Gulf Coast Ultra Deep Royalty Trust operates as a statutory trust. It holds a 5% gross overriding royalty interest in future production from the McMoRan Oil & Gas LLC inboard lower tertiary/cretaceous exploration prospects located in the shallow waters of the Gulf of Mexico and onshore in South Louisiana. The company was incorporated in 2012 and is based in Houston, Texas.

NASDAQ ended the session with Gulf Coast Ultra Deep Royalty Trust rising 8.72% to $0.01 on Thursday, following the last session’s upward trend. NASDAQ rose 1.68% to $16,442.20, following the last session’s downward trend on what was an all-around up trend exchanging session today.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 122.21%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Apr 27, 2023, the estimated forward annual dividend rate is 0.01 and the estimated forward annual dividend yield is 62.69%.

Yearly Top and Bottom Value

Gulf Coast Ultra Deep Royalty Trust’s stock is valued at $0.01 at 17:32 EST, way under its 52-week high of $0.02 and way above its 52-week low of $0.01.

Moving Average

Gulf Coast Ultra Deep Royalty Trust’s worth is way under its 50-day moving average of $0.01 and way under its 200-day moving average of $0.01.

Revenue Growth

Year-on-year quarterly revenue growth declined by 99.8%, now sitting on 1.13M for the twelve trailing months.

More news about Gulf Coast Ultra Deep Royalty Trust.

3. Niu Technologies (NIU) – 8.4%

Niu Technologies designs, manufactures, and sells smart electric scooters in the People's Republic of China. The company offers RQi, NQi, MQi, SQi, UQi, and Gova series electric scooters and motorcycles; KQi series one kick-scooters; BQi series e-bikes; and Niu Aero Sports Bicycles. It also provides accessories and spare parts under the NIU brand name comprising scooter accessories, such as raincoats, gloves, knee pads, storage baskets and tail boxes, smart phone holders, backrests, and locks; lifestyle accessories, which includes T-shirts, coats, sweaters and hoodies, jeans, hats, bags, jewelry, notebook, badges, key chain, and mugs; and performance upgrade components that comprises of upgraded wheels, shock absorbers, brake calipers, and carbon fiber body panels. In addition, the company, through its NIU app, offers online repair request, DIY repairs, service station locator, theft reporting, smart check, and smart services, as well as NIU cover, which provides insurance services. Niu Technologies sells and services its products through city partners and franchised stores, distributors, and third-party e-commerce platforms and the company's online store. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with Niu Technologies jumping 8.4% to $2.39 on Thursday while NASDAQ rose 1.68% to $16,442.20.

Earnings Per Share

As for profitability, Niu Technologies has a trailing twelve months EPS of $-0.32.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.94%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Niu Technologies’s stock is considered to be oversold (<=20).

Moving Average

Niu Technologies’s worth is way above its 50-day moving average of $1.91 and way under its 200-day moving average of $2.86.

Yearly Top and Bottom Value

Niu Technologies’s stock is valued at $2.39 at 17:32 EST, way below its 52-week high of $4.82 and way above its 52-week low of $1.57.

More news about Niu Technologies.

4. Matterport
(MTTR) – 7.89%

Matterport, Inc., a spatial data company, focuses on digitization and datafication in the United States and internationally. The company offers Matterport Capture Services, a fully managed solution for enterprise subscribers; Matterport Pro3, a 3D camera that scans properties; Matterport Pro2, a 3D camera that captures spaces; LEICA BLK360, a device to create digital twins; Smartphone Capture, a smartphone capture solution for both iOS and Android; and 360 Cameras. It also provides Matterport Axis, a motor-mount accessory for smartphone. The company serves its products in residential and commercial real estate, facilities management and retail, AEC, insurance and repair, and travel and hospitality markets. Matterport, Inc. is headquartered in Sunnyvale, California.

NASDAQ ended the session with Matterport
rising 7.89% to $2.05 on Thursday while NASDAQ rose 1.68% to $16,442.20.

Earnings Per Share

As for profitability, Matterport
has a trailing twelve months EPS of $-0.66.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -35.77%.

Volume

Today’s last reported volume for Matterport
is 2155380 which is 17.69% below its average volume of 2618700.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Matterport
‘s EBITDA is 1.42.

Sales Growth

Matterport
‘s sales growth for the current quarter is 5.5%.

More news about Matterport
.

5. Matterport
(MTTR) – 7.89%

Matterport, Inc., a spatial data company, focuses on digitization and datafication in the United States and internationally. The company offers Matterport Capture Services, a fully managed solution for enterprise subscribers; Matterport Pro3, a 3D camera that scans properties; Matterport Pro2, a 3D camera that captures spaces; LEICA BLK360, a device to create digital twins; Smartphone Capture, a smartphone capture solution for both iOS and Android; and 360 Cameras. It also provides Matterport Axis, a motor-mount accessory for smartphone. The company serves its products in residential and commercial real estate, facilities management and retail, AEC, insurance and repair, and travel and hospitality markets. Matterport, Inc. is headquartered in Sunnyvale, California.

NASDAQ ended the session with Matterport
jumping 7.89% to $2.05 on Thursday while NASDAQ jumped 1.68% to $16,442.20.

Earnings Per Share

As for profitability, Matterport
has a trailing twelve months EPS of $-0.66.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -35.77%.

Sales Growth

Matterport
‘s sales growth for the current quarter is 5.5%.

More news about Matterport
.

6. Fiverr (FVRR) – 7.86%

Fiverr International Ltd. operates an online marketplace worldwide. Its platform enables sellers to sell their services and buyers to buy them. The company's platform includes various categories in ten verticals, including graphic and design, digital marketing, writing and translation, video and animation, music and audio, programming and tech, business, data, lifestyle, and photography. It also offers value-added products, including subscription-based content marketing, back-office, learning and development offerings, creative talent, and freelancer management platforms. In addition, the company provides a suite of professional solutions that enable businesses to engage with freelancers; Fiverr Pro, a marketplace; Fiverr Certified, a storefront to access certified experts for partner vendors; Fiverr Enterprise, a gateway to source and manage on-demand and long-term freelancers. Further, it offers various value-added products, including Promoted Gigs which allows sellers to advertise their services on the platform; and Seller Plus, a subscription program that equips sellers with advanced tools. The company's buyers include businesses of various sizes, as well as sellers comprise a group of freelancers and agencies. Fiverr International Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.

NYSE ended the session with Fiverr rising 7.86% to $20.73 on Thursday, after two successive sessions in a row of losses. NYSE fell 0.18% to $17,915.20, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Fiverr has a trailing twelve months EPS of $0.09.

PE Ratio

Fiverr has a trailing twelve months price to earnings ratio of 230.33. Meaning, the purchaser of the share is investing $230.33 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.82%.

Moving Average

Fiverr’s worth is way under its 50-day moving average of $25.76 and way under its 200-day moving average of $27.51.

Volume

Today’s last reported volume for Fiverr is 3016880 which is 206.63% above its average volume of 983859.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 88.5% and 36.1%, respectively.

More news about Fiverr.

7. iShares FTSE EPRA/NAREIT Europe (IFEU) – 7.21%

NASDAQ ended the session with iShares FTSE EPRA/NAREIT Europe jumping 7.21% to $35.08 on Thursday, after five consecutive sessions in a row of losses. NASDAQ jumped 1.68% to $16,442.20, following the last session’s downward trend on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, iShares FTSE EPRA/NAREIT Europe has a trailing twelve months EPS of $3.47.

More news about iShares FTSE EPRA/NAREIT Europe.

8. Hudson Global (HSON) – 6.41%

Hudson Global, Inc. provides talent solutions for mid-to-large-cap multinational companies and government agencies under the Hudson RPO brand in the Americas, the Asia Pacific, and Europe. It offers recruitment process outsourcing (RPO) services, such as recruitment outsourcing, project-based outsourcing, contingent workforce solutions, and recruitment consulting for clients' permanent staff hires; and RPO contracting services, including outsourced professional contract staffing and managed services. The company was formerly known as Hudson Highland Group, Inc. and changed its name to Hudson Global, Inc. in April 2012. Hudson Global, Inc. was founded in 1999 and is headquartered in Old Greenwich, Connecticut.

NASDAQ ended the session with Hudson Global jumping 6.41% to $17.59 on Thursday, after two consecutive sessions in a row of gains. NASDAQ rose 1.68% to $16,442.20, following the last session’s downward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, Hudson Global has a trailing twelve months EPS of $0.7.

PE Ratio

Hudson Global has a trailing twelve months price to earnings ratio of 25.13. Meaning, the purchaser of the share is investing $25.13 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.66%.

More news about Hudson Global.

9. Lyft (LYFT) – 6.09%

Lyft, Inc. operates a peer-to-peer marketplace for on-demand ridesharing in the United States and Canada. It operates multimodal transportation networks that offer access to various transportation options through the Lyft platform and mobile-based applications. The company's platform provides a ridesharing marketplace, which connects drivers with riders; Express Drive, a car rental program for drivers; and a network of shared bikes and scooters in various cities to address the needs of riders for short trips. It also offers centralized tools and enterprise transportation solutions, such as concierge transportation solutions for organizations; Lyft Pink subscription plans; Lyft Pass commuter programs; first-mile and last-mile services; and university safe rides programs. The company was formerly known as Zimride, Inc. and changed its name to Lyft, Inc. in April 2013. Lyft, Inc. was incorporated in 2007 and is headquartered in San Francisco, California.

NASDAQ ended the session with Lyft jumping 6.09% to $19.52 on Thursday, following the last session’s downward trend. NASDAQ rose 1.68% to $16,442.20, following the last session’s downward trend on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, Lyft has a trailing twelve months EPS of $-0.88.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -73.17%.

Volatility

Lyft’s last week, last month’s, and last quarter’s current intraday variation average was 2.05%, 0.03%, and 3.41%.

Lyft’s highest amplitude of average volatility was 2.09% (last week), 2.51% (last month), and 3.41% (last quarter).

Earnings Before Interest, Taxes, Depreciation, and Amortization

Lyft’s EBITDA is 1.52.

Moving Average

Lyft’s value is way higher than its 50-day moving average of $14.37 and way above its 200-day moving average of $11.86.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Lyft’s stock is considered to be oversold (<=20).

More news about Lyft.

10. Karyopharm Therapeutics (KPTI) – 5.51%

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1). Its lead compound, include XPOVIO in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma; in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma; and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). The company is also developing Selinexor for treating hematological and solid tumor malignancies, including multiple myeloma, endometrial cancer, myelofibrosis, and DLBCL; and ELTANEXOR for treating Myelodysplastic Neoplasms, as well as verdinexor, KPT-9274, and IL-12 compounds. The company has license agreement with Menarini Group to develop and commercialize selinexor for human oncology indications; license agreement with Antengene Therapeutics Limited to develop and commercialize selinexor, eltanexor, and KPT-9274 for the treatment and/or prevention of human oncology indications, as well as verdinexor for the diagnosis, treatment, and/or prevention of human non-oncology indications; and distribution agreement for the commercialization of XPOVIO with FORUS Therapeutics Inc. Further, it has a collaboration with Bristol Myers Squibb to evaluate novel cereblon E3 ligase modulator agent mezigdomide in combination with Selinexor in patients with relapsed/refractory multiple myeloma The company was incorporated in 2008 and is headquartered in Newton, Massachusetts.

NASDAQ ended the session with Karyopharm Therapeutics jumping 5.51% to $1.34 on Thursday while NASDAQ rose 1.68% to $16,442.20.

Earnings Per Share

As for profitability, Karyopharm Therapeutics has a trailing twelve months EPS of $-1.25.

More news about Karyopharm Therapeutics.

Losers Today

1. Nikola (NKLA) – -26.73%

Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions in the United States and internationally. The company operates in truck and energy units. It commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) to the trucking sector. In addition, it develops a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. Further, its products include Nikola Tre Class 8 truck and the Nikola's Class 8 FCEV. Additionally, the company assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation founded in 2015 and is headquartered in Phoenix, Arizona.

NASDAQ ended the session with Nikola dropping 26.73% to $0.72 on Thursday, after three sequential sessions in a row of losses. NASDAQ rose 1.68% to $16,442.20, following the last session’s downward trend on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, Nikola has a trailing twelve months EPS of $-1.21.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -138.82%.

Previous days news about Nikola

• Nikola (nkla) stock dips while market gains: key facts. According to Zacks on Tuesday, 9 April, "The most recent trading session ended with Nikola (NKLA Quick QuoteNKLA – Free Report) standing at $1, reflecting a -0.99% shift from the previouse trading day’s closing. ", "Any recent changes to analyst estimates for Nikola should also be noted by investors. "

More news about Nikola.

2. Canopy Growth (CGC) – -10.64%

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

NASDAQ ended the session with Canopy Growth sliding 10.64% to $8.15 on Thursday while NASDAQ jumped 1.68% to $16,442.20.

Earnings Per Share

As for profitability, Canopy Growth has a trailing twelve months EPS of $-15.67.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -121.56%.

More news about Canopy Growth.

3. CarMax (KMX) – -9.23%

CarMax, Inc., together with its subsidiaries, operates as a retailer of used vehicles in the United States. It operates in two segments, CarMax Sales Operations and CarMax Auto Finance. The company offers customers a range of makes and models of used vehicles, including domestic, imported, and luxury vehicles, as well as hybrid and electric vehicles; and extended protection plans to customers at the time of sale, as well as sells vehicles that are approximately 10 years old and has more than 100,000 miles through wholesale auctions. It also provides reconditioning and vehicle repair services; and financing alternatives for retail customers across a range of credit spectrum through its CarMax Auto Finance and arrangements with various financial institutions. The company was founded in 1993 and is based in Richmond, Virginia.

NYSE ended the session with CarMax falling 9.23% to $71.98 on Thursday while NYSE slid 0.18% to $17,915.20.

Earnings Per Share

As for profitability, CarMax has a trailing twelve months EPS of $3.13.

PE Ratio

CarMax has a trailing twelve months price to earnings ratio of 23. Meaning, the purchaser of the share is investing $23 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.64%.

More news about CarMax.

4. GlycoMimetics (GLYC) – -8.58%

GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing GMI-1359, which targets e-selectin and a chemokine receptor for the treatment of cancers that affect the bone and bone marrow, including solid tumors. It also develops various other programs, including GMI-1687, an antagonist of E-selectin to treat vaso-occlusive crisis; and galectin-3 antagonists, a carbohydrate-binding protein. The company has a cooperative research and development agreement with the National Cancer Institute; and a collaboration and license agreement with Apollomics (Hong Kong) Limited for the development and commercialization of uproleselan and GMI-1687. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland.

NASDAQ ended the session with GlycoMimetics sliding 8.58% to $2.45 on Thursday while NASDAQ jumped 1.68% to $16,442.20.

Earnings Per Share

As for profitability, GlycoMimetics has a trailing twelve months EPS of $-0.63.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -80.42%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

GlycoMimetics’s EBITDA is -10.83.

Moving Average

GlycoMimetics’s worth is way below its 50-day moving average of $2.95 and way above its 200-day moving average of $2.05.

Volume

Today’s last reported volume for GlycoMimetics is 957161 which is 156.34% above its average volume of 373385.

More news about GlycoMimetics.

5. Harvard Bioscience (HBIO) – -7.99%

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. The company was founded in 1901 and is based in Holliston, Massachusetts.

NASDAQ ended the session with Harvard Bioscience dropping 7.99% to $4.26 on Thursday while NASDAQ rose 1.68% to $16,442.20.

Earnings Per Share

As for profitability, Harvard Bioscience has a trailing twelve months EPS of $-0.08.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.7%.

Yearly Top and Bottom Value

Harvard Bioscience’s stock is valued at $4.26 at 17:32 EST, way under its 52-week high of $6.29 and way above its 52-week low of $3.80.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is a negative 66.7% and positive 50% for the next.

More news about Harvard Bioscience.

6. Gevo (GEVO) – -7.18%

Gevo, Inc. operates as a carbon abatement company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company focuses on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels. It offers renewable gasoline and diesel, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.

NASDAQ ended the session with Gevo dropping 7.18% to $0.65 on Thursday, after two sequential sessions in a row of losses. NASDAQ jumped 1.68% to $16,442.20, following the last session’s downward trend on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, Gevo has a trailing twelve months EPS of $-0.28.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -11.39%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Gevo’s EBITDA is -2.11.

More news about Gevo.

7. The Hain Celestial Group (HAIN) – -7.13%

The Hain Celestial Group, Inc. manufactures, markets, and sells organic and natural products in United States, United Kingdom, Europe, and internationally. It operates through two segments: North America and International. The company offers infant formula; infant, toddler, and kids' food; plant-based beverages and frozen desserts, such as soy, rice, oat, and spelt; and condiments. It also provides cooking and culinary oils; cereal bars; fresh and aseptic soups; yogurts; and nut butters. In addition, the company offers hot-eating desserts, refrigerated and frozen plant-based meat-alternative products, jams, fruit spreads, jellies, honey, natural sweeteners, syrups, dessert sauces, and marmalade products, as well as other food products. Further, it provides snack products comprising potato, root vegetable and other exotic vegetable chips, straws, tortilla chips; and personal care products that include hand, skin, hair, and oral care products, as well as deodorants, baby food, sunscreens, and other products under the Alba Botanica, Avalon Organics, Earth's Best, JASON, Live Clean, and Queen Helene brands name. Additionally, the company offers herbal, green, black, wellness, rooibos, and chai tea under the Celestial Seasonings brand. It sells pantry products under the Spectrum, Spectrum Essentials, MaraNatha, Imagine broths, Hain Pure Foods, Health Valley, and Hollywood brands. It sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce retailers, food service channels and clubs, and drug and convenience stores. The company was incorporated in 1993 and is headquartered in Hoboken, New Jersey.

NASDAQ ended the session with The Hain Celestial Group falling 7.13% to $6.25 on Thursday, following the last session’s downward trend. NASDAQ jumped 1.68% to $16,442.20, following the last session’s downward trend on what was an all-around bullish trend exchanging session today.

Earnings Per Share

As for profitability, The Hain Celestial Group has a trailing twelve months EPS of $-1.77.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.05%.

Yearly Top and Bottom Value

The Hain Celestial Group’s stock is valued at $6.25 at 17:32 EST, way below its 52-week high of $18.33 and above its 52-week low of $6.22.

Volume

Today’s last reported volume for The Hain Celestial Group is 1590560 which is 33.63% above its average volume of 1190250.

Earnings Before Interest, Taxes, Depreciation, and Amortization

The Hain Celestial Group’s EBITDA is 177.49.

More news about The Hain Celestial Group.

8. Innodata (INOD) – -7.1%

Innodata Inc. operates as a global data engineering company in the United States, the United Kingdom, the Netherlands, Canada, and internationally. The company operates through three segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment engages in the provision of AI data preparation services; collecting or creating training data; annotating training data; and training AI algorithms for its customers, as well as AI model deployment and integration services. This segment also provides a range of data engineering support services, including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management. The Synodex segment offers an industry platform that transforms medical records into useable digital data with its proprietary data models or client data models. The Agility segment provides an industry platform that offers marketing communications and public relations professionals to target and distribute content to journalists and social media influencers; and to monitor and analyze global news channels, such as print, web, radio, and TV, as well as social media channels. It serves banking, insurance, financial services, technology, digital retailing, and information/media sectors through its professional staff, senior management, and direct sales personnel. The company was formerly known as Innodata Isogen, Inc. and changed its name to Innodata Inc. in June 2012. Innodata Inc. was incorporated in 1988 and is headquartered in Ridgefield Park, New Jersey.

NASDAQ ended the session with Innodata falling 7.1% to $6.28 on Thursday, following the last session’s downward trend. NASDAQ jumped 1.68% to $16,442.20, following the last session’s downward trend on what was an all-around bullish trend exchanging session today.

Earnings Per Share

As for profitability, Innodata has a trailing twelve months EPS of $-0.03.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.13%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 34.8%, now sitting on 86.78M for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Innodata’s EBITDA is 70.2.

Yearly Top and Bottom Value

Innodata’s stock is valued at $6.28 at 17:32 EST, way under its 52-week high of $15.36 and way above its 52-week low of $5.57.

Volume

Today’s last reported volume for Innodata is 262660 which is 51.06% below its average volume of 536754.

More news about Innodata.

9. Fastenal Company (FAST) – -6.5%

Fastenal Company, together with its subsidiaries, engages in the wholesale distribution of industrial and construction supplies in the United States, Canada, Mexico, North America, and internationally. It offers fasteners, and related industrial and construction supplies under the Fastenal name. The company's fastener products include threaded fasteners, bolts, nuts, screws, studs, and related washers that are used in manufactured products and construction projects, as well as in the maintenance and repair of machines. It also offers miscellaneous supplies and hardware, including pins, machinery keys, concrete anchors, metal framing systems, wire ropes, strut products, rivets, and related accessories. The company serves the manufacturing market comprising original equipment manufacturers; maintenance, repair, and operations customers; non-residential construction market; farmers, truckers, railroads, mining companies, schools, and retail trades; and oil exploration, production, and refinement companies, as well as federal, state, and local governmental entities. Fastenal Company was founded in 1967 and is headquartered in Winona, Minnesota.

NASDAQ ended the session with Fastenal Company dropping 6.5% to $69.88 on Thursday while NASDAQ rose 1.68% to $16,442.20.

Earnings Per Share

As for profitability, Fastenal Company has a trailing twelve months EPS of $2.02.

PE Ratio

Fastenal Company has a trailing twelve months price to earnings ratio of 34.59. Meaning, the purchaser of the share is investing $34.59 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.47%.

Yearly Top and Bottom Value

Fastenal Company’s stock is valued at $69.88 at 17:32 EST, below its 52-week high of $76.59 and way higher than its 52-week low of $50.30.

Volume

Today’s last reported volume for Fastenal Company is 10940500 which is 173.88% above its average volume of 3994610.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 1.9% and 7.7%, respectively.

More news about Fastenal Company.

10. Xenetic Biosciences (XBIO) – -6.16%

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

NASDAQ ended the session with Xenetic Biosciences sliding 6.16% to $4.43 on Thursday, following the last session’s downward trend. NASDAQ jumped 1.68% to $16,442.20, following the last session’s downward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-2.71.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -34.98%.

Sales Growth

Xenetic Biosciences’s sales growth for the current quarter is 39.9%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 47.5%, now sitting on 2.35M for the twelve trailing months.

More news about Xenetic Biosciences.

Stay up to date with our winners and losers daily report